Fidelity, Scalable, Non-Toxic On-Premises Biofoundry CapabilitiesSAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader ...

SAN DIEGO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- A new partnership between Telesis Bio and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, will create ...

Shares of Telesis Bio, Inc. TBIO rose sharply in today's pre-market trading session after the company announced a partnership ...

Shares of Telesis Bio were trading at double their closing price in the after-hours market following news the company entered a collaboration deal with Beckman Coulter Life Sciences.

Telesis Bio and Beckman Coulter Life Sciences announced an new partnership on Thursday. The companies aim to revolutionize DNA and mRNA synthesis by creating efficient and scalable biofoundries.

Shares of Telesis Bio (NASDAQ:TBIO) surged ~110% in the premarket on Thursday after the nano-cap life sciences company ...

At Beckman Coulter, innovation doesn't stop with our liquid handling systems. Our Biomek Tips and Labware have been specifically tailored to meet the growing laboratory needs in genomics ...

A broad menu of high quality assays from Beckman Coulter, plus new, productivity-enhancing features on the Access 2 offer laboratories a flexible option for immunoassay testing.

Biotech companies could gain the financial flexibility to accelerate their innovations with the Fed’s recent rate cut. To ...